Atheric™ Pharmaceutical LLC
  • Founded: 2016
  • CEO: Robert Malone, MD
  • Funding Source:
  • Development Stage:

Atheric™ Pharmaceutical LLC is a biopharmaceutical company focused on the rapid development and commercialization of re-purposed drugs to prevent and treat Zika and other Flavivirus disease.  Atheric’s lead drug products are reformulated broad spectrum antiviral drugs that inhibit autophagy-dependent viral replication as well as other anti-viral pathways.  Atheric is committed to providing broad-spectrum medical countermeasures for Zika and other neglected tropical diseases